l carnitine and heart health l-Carnitine disease Role of L-carnitine in Cardiovascular

Synthesis of Highly Fluorescent Carbon Quantum Dots from Rubber Seed Shells for the Adsorption and Photocatalytic Degradation of Dyes

doi: 10.1159/000351424 120 AnanFMasakiTIwaoTEtoTShimomuraTUmenoYet al

Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A

NIH has released four new SBIR/STTR solicitations (first deadline for all solicitations is September 8, 2026): Parent SBIR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track SBIR awards Parent STTR (Clinical Trial Optional) accepts Phase I, Phase II, Direct-to-Phase II, and Fast-Track STTR awards SBIR Phase IIB Strategic Breakthrough Award (Clinical Trial Optional) accepts Phase IIB Strategic Breakthrough SBIR awards (for Phase II awardees) SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Clinical Trial Optional) accepts CRP awards (for Phase II awardees) Updated summaries of the research interests, budget waiver topics, and award mechanisms supported by individual Institutes and Centers (ICs) are now housed on the Small Business Funding Considerations and Contacts webpage

Nitrogen functionalization, dehydration and strengthening the -conjugation, etc

ROS can inhibit SERCA function by both interfering with the ATP binding site and by uncoupling calcium uptake from ATP hydrolysis (356, 414)